Nuzenio

Pmlive

Pmlive entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

US FDA accepts supplemental Biologics License Application for Merck’s Enflonsia - PMLiVEPMLiVE · Fri, 07 Aug 2026 10:55:00 GMTSaatchi & Saatchi Health London appoint Pedro Rosa and May Leen Wong - PMLiVEPMLiVE · Fri, 07 Aug 2026 10:50:00 GMTNovartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer - PMLiVEPMLiVE · Mon, 03 Aug 2026 11:55:35 GMTPharmaceutical Market Europe – July/August 2026 - PMLiVEPMLiVE · Thu, 30 Jul 2026 16:40:31 GMTInizio launches Connected Insights - PMLiVEPMLiVE · Thu, 30 Jul 2026 12:06:49 GMT

Timeline

Fri, 07 Aug 2026 10:55:00 GMTUS FDA accepts supplemental Biologics License Application for Merck’s Enflonsia - PMLiVE
Fri, 07 Aug 2026 10:50:00 GMTSaatchi & Saatchi Health London appoint Pedro Rosa and May Leen Wong - PMLiVE
Mon, 03 Aug 2026 11:55:35 GMTNovartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer - PMLiVE
Thu, 30 Jul 2026 16:40:31 GMTPharmaceutical Market Europe – July/August 2026 - PMLiVE
Thu, 30 Jul 2026 12:06:49 GMTInizio launches Connected Insights - PMLiVE

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pmlive.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.